In particular, ADSL expression has been shown to be significantly upregulated and to be oncogenic in triple-negative breast cancer by enhancing tumor growth and invasiveness, at least partially through the regulation of the long non-coding RNA MIR22HG and, indirectly, cMYC and cMYC target genes expression 6. Here, ADSL is linked to triple-negative breast carcinoma.